Skip to main content
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · IEX Real-Time Price · USD
6.97
-0.68 (-8.89%)
May 20, 2024, 1:41 PM EDT - Market open

ImmunityBio Market Cap

ImmunityBio has a market cap or net worth of $4.84 billion as of May 20, 2024. Its market cap has increased by 297.52% in one year.

Market Cap
4.84B
Enterprise Value
5.56B
1-Year Change
297.52%
Ranking
#1230
Category
Mid-Cap
Stock Price
$6.97

Market Cap Chart

Since July 28, 2015, ImmunityBio's market cap has increased from $2.67B to $4.84B, an increase of 81.37%. That is a compound annual growth rate of 6.99%.

History

DateMarket Cap% Change
May 17, 20245.29B-1.29%
May 16, 20245.36B-4.32%
May 15, 20245.60B-3.57%
May 14, 20245.81B-2.66%
May 13, 20245.97B6.28%
May 10, 20245.62B0.74%
May 9, 20245.57B4.43%
May 8, 20245.34B-4.12%
May 7, 20245.57B5.76%
May 6, 20245.26B-14.64%
May 3, 20246.17B2.01%
May 2, 20246.05B5.04%
May 1, 20245.76B6.88%
Apr 30, 20245.38B-11.12%
Apr 29, 20246.06B22.31%
Apr 26, 20244.95B43.83%
Apr 25, 20243.44B6.02%
Apr 24, 20243.25B-12.21%
Apr 23, 20243.70B11.13%
Apr 22, 20243.33B-6.26%
Apr 19, 20243.55B7.33%
Apr 18, 20243.31B-6.30%
Apr 17, 20243.53B6.51%
Apr 16, 20243.32B-6.11%
Apr 15, 20243.53B2.54%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
BridgeBio Pharma 5.63B
Organon & Co. 5.61B
Glaukos 5.53B
Lantheus Holdings 5.52B
Ionis Pharmaceuticals 5.45B
R1 RCM 5.24B
Doximity 5.23B
Option Care Health 5.18B
Market Cap Rankings